| Lost password
33 users onlineYou are not loggend in.  Login
Clinical Trial info
 1
 1
06/04/2001 23:55
Chris Bacon

not registered

06/04/2001 23:55
Chris Bacon

not registered

Clinical Trial info

Do the following to see some info about the clinical trials:

1. Go to:
http://clinicaltrials.gov
2. Enter "dupuytren" (without the double quotes)
and click the "Search" button
3. Check the one that says "Recruiting Phase II ..."
and click the "Display Selected Studies" button
4. Read the "Eligibility" conditions
5. Scroll down to "Location and Contact Information"

06/06/2001 23:42
JIm H

not registered

06/06/2001 23:42
JIm H

not registered

Phase II status

I'm confused by the information on that site, I thought the Phase II trial were completed quite a while ago. I think maybe they were, and the web page is in error. Or maybe they're doing another Phase II trial before beginning Phase III?

06/09/2001 23:24
Chris Bacon

not registered

06/09/2001 23:24
Chris Bacon

not registered

Phase II status

I've been confused by it as well. Some of the things I've read seem to imply Phase II is done, but I think they're just saying that Phase II results (so far) have been encouraging. Since it's a ".gov" site, presumably ClinicalTrials.gov is accurate. It also has a note saying it was updated fairly recently (May, I think).

06/12/2001 23:34
Jim H

not registered

06/12/2001 23:34
Jim H

not registered

info

I've been thinking about buying a few shares of BSTC stock as a way of getting some information about what's really going on.

06/13/2001 23:06
Chris Bacon

not registered

06/13/2001 23:06
Chris Bacon

not registered

info

There is a fair amount of info from this link on their site:

Investor's Digest: http://www.globalprovince.com/BSTC.htm

Do "Edit... Find" with dupuytren to step through all the references on the page.

A 5/24/01 press release does say that the Phase II trials have been successfully completed and that they're preparing a report for the FDA.

Curiously, though, there's a 9/14/2000 press release that says: "BioSpecifics reports that a Phase II trial has been completed for an injectable Collagenase enzyme, Cordase, for Dupuytren's disease." So, what happened with the Phase II trials in the 1.5 years between these press releases?

There's also a 4/28/2000 press release that talks about completing a Phase II trial. Sounds like there are multiple "trials" and they toot their horn every time one is completed, without saying anything about how many more are not complete. Cute.

06/13/2001 23:12
jim h

not registered

06/13/2001 23:12
jim h

not registered

Phase 111

Check the graph of BSTC stock over the last few years and it's pretty obvious they have some disappointed investors. This can lead to fluffy press releases about non-events - maybe that's what's happened here. But recently their stock has taken a hop upward so they might feel freer to release some solid information.

I guess we can speculate endlessly but without some word from BSTC, we don't have much to go on. It might be that more is discoverable from the FDA but only with considerable effort.

06/17/2001 23:41
Jim H

not registered

06/17/2001 23:41
Jim H

not registered

Phase 111

Acccording to this BSTC press release, Phase II trials are complete:

http://biz.yahoo.com/prnews/010618/nym026.html

07/22/2001 23:53
Jay

not registered

07/22/2001 23:53
Jay

not registered

Phase 111

Candidates for Phase 111 are being actively recruited at this time. 2 centers for the trial are University of NY @ Stonybrook and Stanford Hand Clinic in Palo Alto, CA. Doctor @ At Sanford is Dr. Vincent Hentz tel# 650-723-5256, fax# 650-725-5223. I will be a subject in this test, and Dr. Hentz expects the trial to begin sept/oct 2001.

02/19/2005 23:24
Chris Bacon

not registered

02/19/2005 23:24
Chris Bacon

not registered

Clinical Trial info

I heard that the Phase III trials are underway. Do amy of you have news about this?

 1
 1
Collagenase   successfully   650-723-5256   clinicaltrials   Stonybrook   conditions   completing   discoverable   completed   disappointed   considerable   encouraging   Information   release   Recruiting   globalprovince   650-725-5223   dupuytren   Eligibility   BioSpecifics